Your search returned 2 results.

Sort
Results
1.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors:
  • Waksman, Ron
PMID:
  • 26470647
Year: 2016
Citation:
  • Lancet. 387(10013):31-9, 2016 Jan 2.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Clinical Study
  • Journal Article
  • Multicenter Study
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W
2.
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. MedStar authors:
  • Weissman, Neil J
PMID:
  • 23872647
Year: 2013
Citation:
  • Eurointervention. 9(3):308-15, 2013 Jul.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Allocco DJ, Banning A, Barragan P, Dawkins KD, Kelbaek H, Kubica J, Masotti M, Meredith IT, Scott D, Sjogren I, Stables RH, Thuesen L, Valdes Chavarri M, Verheye S, Walters DL, Weissman NJ, West NE, Whitbourn R
Pages

Powered by Koha